Search
01/06/2023
The Bittersweet Beat: Diabetes Complications
Rossell, J, Rojo-Lopez, MI, Julve, J, Mauricio, D. The Bittersweet Beat: Diabetes Complications. Journal of Clinical Medicine. 2023; 12(12)DOI:10.3390/jcm12124018. PMID:37373711. IF:3.000(Q1/2D).
17/05/2023
Hybrid closed-loop systems can help patients with extreme fear of hypoglycemia or hyperglycemia
Mangas, N, Mateu-Salat, M, Martinez, MJ, Lopez, A, Pujol, I, Martinez, C, Corcoy, R. Hybrid closed-loop systems can help patients with extreme fear of hypoglycemia or hyperglycemia. Hormones-International Journal of Endocrinology and Metabolism. 2023; 22(3)DOI:10.1007/s42000-023-00451-9. PMID:37198528. IF:2.400(Q3/7D).
11/05/2023
Contribution of Elevated Glucose and Oxidized LDL to Macrophage Inflammation: A Role for PRAS40/Akt-Dependent Shedding of Soluble CD14
Sanjurjo, L, Castelblanco, E, Julve, J, Villalmanzo, N, Tellez, E, Ramirez-Morros, A, Alonso, N, Mauricio, D, Sarrias, MR. Contribution of Elevated Glucose and Oxidized LDL to Macrophage Inflammation: A Role for PRAS40/Akt-Dependent Shedding of Soluble CD14. Antioxidants. 2023; 12(5)DOI:10.3390/antiox12051083. PMID:37237950. IF:6.000(Q1/2D).
08/05/2023
Lower risk of cardiovascular events and death associated with initiation of sodium-glucose cotransporter-2 inhibitors versus sulphonylureas: Analysis from the CVD-REAL 2 study
Goh, SY, Kosiborod, MN, Lam, CSP, Cavender, MA, Kohsaka, S, Norhammar, A, Birkeland, KI, Holl, RW, Mauricio, D, Tangri, N, Shaw, JE, Thuresson, M, Fenici, P, Kim, DJ. Lower risk of cardiovascular events and death associated with initiation of sodium-glucose cotransporter-2 inhibitors versus sulphonylureas: Analysis from the CVD-REAL 2 study. DIABETES OBESITY & METABOLISM. 2023; 25(8)DOI:10.1111/dom.15092. PMID:37055714. IF:5.400(Q1/2D).
01/05/2023
Gestational weight gain and pregnancy outcomes in women with type 1 and type 2 diabetes mellitus
Xie X., Liu J., García-Patterson A., Chico A., Mateu-Salat M., Amigó J., Adelantado J.M., Corcoy R.. Gestational weight gain and pregnancy outcomes in women with type 1 and type 2 diabetes mellitus. ACTA DIABETOLOGICA. 2023; 60(5)DOI:10.1007/s00592-023-02031-0. PMID:36707439. IF:3.100(Q2/5D).
01/05/2023
Research Priorities for Precision Medicine in NAFLD
Iruzubieta, P, Bataller, R, Arias-Loste, MT, Arrese, M, Calleja, JL, Castro-Narro, G, Cusi, K, Dillon, JF, Martinez-Chantar, ML, Mateo, M, Perez, A, Rinella, ME, Romero-Gomez, M, Schattenberg, JM, Zelber-Sagi, S, Crespo, J, Lazarus, JV. Research Priorities for Precision Medicine in NAFLD. Clinics in Liver Disease. 2023; 27(2)DOI:10.1016/j.cld.2023.01.016. PMID:37024222. IF:2.900(Q2/5D).